Clinical Investigations in Primary Care

Frontiers of Neurology and Neuroscience

Volumn 24, Issue , 2009, Pages 1-11

  De Souza, Leonardo Cruz ^a   Sarazin, Marie ^a,b   Goetz, Celine ^a   Dubois, Bruno ^a  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; CREATININE; CYANOCOBALAMIN; ELECTROLYTE; GLUCOSE; TAU PROTEIN;

AGNOSIA; ALZHEIMER DISEASE; AMNESIA; ANOSOGNOSIA; ANTEROGRADE AMNESIA; APATHY; BEHAVIOR DISORDER; BRADYKINESIA; BRAIN FUNCTION; CAPGRAS SYNDROME; CEREBROSPINAL FLUID; COGNITION; COGNITIVE DEFECT; CORTICOBASAL DEGENERATION; DAILY LIFE ACTIVITY; DELUSION; DEMENTIA; DEPRESSION; DEPTH PERCEPTION; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DISEASE SEVERITY; DISORIENTATION; DYSPRAXIA; EPISODIC MEMORY; EXTRAPYRAMIDAL SYMPTOM; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC MARKER; GESTURE; HALLUCINATION; HOME CARE; HUMAN; HUNTINGTON CHOREA; LANGUAGE DISABILITY; LEARNING DISORDER; LIFE EXPECTANCY; MEDICAL EXAMINATION; MEMORY DISORDER; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; MUSCLE HYPERTONIA; MYOCLONUS; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PARANOIA; PARKINSON DISEASE; PHYSICAL EXAMINATION; PRIMARY MEDICAL CARE; PRION DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN BLOOD LEVEL; PSYCHOSIS; RECALL; REVIEW; SELF CONCEPT; SEMANTIC MEMORY; SHY DRAGER SYNDROME; TEMPORAL LOBE; TREMOR; WORKING MEMORY; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE;

ALZHEIMER DISEASE; HUMANS; NEUROPSYCHOLOGICAL TESTS; PRIMARY HEALTH CARE;

EID: 65349085751     PISSN: 16604431     EISSN: 16622804     Source Type: Book Series    
DOI: 10.1159/000197897     Document Type: Review

References (29)

1. Nestor PJ, Scheltens P, Hodges JR: Advances in the early detection of Alzheimer's disease. Nat Med 2004;10(suppl):S34-S41.
2. De Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Tsui W, Saint Louis LA, Sobanska L, Brys M, Li Y, Rich K, Rinne J, Rusinek H: Imaging and CSF studies in the preclini-cal diagnosis of Alzheimer's disease. Ann N Y Acad Sci 2007;1097:114-145.
3. Cummings JL: Alzheimer's disease. N Engl J Med 2004;351:56-67.
4. Hodges JR: Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects. Brain 2006;129:2811-2822.
5. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-259.
6. Godbolt AK, Cipolotti L, Watt H, Fox NC, Janssen JC, Rossor MN: The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort. Arch Neurol 2004; 61:1743-1748.
7. Grober E, Buschke H, Crystal H, Bang S, Dresner R: Screening for dementia by memory testing. Neurology 1988;38:900-903.
8. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6: 734-746.
9. Tounsi H, Deweer B, Ergis AM, Van der Linden M, Pillon B, Michon A, Dubois B: Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease. Alzheimer Dis Assoc Disord 1999;13:38-46.
10. Dubois B, Slachevsky A, Litvan I, Pillon B: The FAB: a Frontal Assessment Battery at bedside. Neurology 2000;55:1621-1626.
11. Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA: Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci 2006;26:10222-10231.
12. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
13. Folstein MF, Folstein SE, McHugh PR: 'Mini Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
14. Burback D, Molnar FJ, St. John P, Man-Son-Hing M: Key methodological features of randomized controlled trials of Alzheimer disease therapy: minimal clinically important difference, sample size and trial design. Dement Geriatr Cogn Disord 1999; 10:534-540.
15. Sarazin M, Stern Y, Berr C, Riba A, Albert M, Brandt J, Dubois B: Neuropsychological predictors of dependency in patients with Alzheimer disease. Neurology 2005;64:1027-1031.
16. Starkstein SE, Jorge R, Mizrahi R, Robinson RG: A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006;77:8-11.
17. Scarmeas N, Albert M, Brandt J, Blacker D, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Wegesin D, Marder K, Bell K, Honig L, Stern Y: Motor signs predict poor outcomes in Alzheimer disease. Neurology 2005;64:1696-1703.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
19. Blacker D, Albert MS, Bassett SS, Go RC, Harrell LE, Folstein MF: Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. Arch Neurol 1994;51:1198-1204.
20. Pillon B, Deweer B, Agid Y, Dubois B: Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch Neurol 1993;50:374-379.
21. Sarazin M, Berr C, De Rotrou J, Fabrigoule C, Pasquier F, Legrain S, Michel B, Puel M, Volteau M, Touchon J, Verny M, Dubois B: Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology 2007;69:1859-1867.
22. Sampson EL, Warren JD, Rossor MN: Young onset dementia. Postgrad Med J 2004;80:125-139.
23. Buerger K, Ewers M, Pirttila T, Zinkowski R, Alafuzoff I, Teipel SJ, DeBernardis J, Kerkman D, McCulloch C, Soininen H, Hampel H: CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain 2006;129:3035-3041.
24. Hampel H, Bürger K, Prussner JC, Zinkowski R, DeBernardis J, Kerkman D, Leinsinger G, Evans AC, Davies P, Möller HJ, Teipel SJ: Correlation of cerebrospinal fluid levels of tau protein phosphory-lated at threonine 231 with rates of hippocampal atrophy in Alzheimer Disease. Arch Neurol 2005;62:770-773.
25. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006;5:228-234.
26. Ewers M, Buerger K, Teipel SJ, Scheltens P, Schröder J, Zinkowski R P, Bouwman FH, Schönknecht P, Schoonenboom NS, Andreasen N, Wallin A, DeBernardis JF, Kerkman DJ, Heindl B, Blennow K, Hampel H: Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI. Neurology 2007;69:2205-2212.
27. Li G, Sokal I, Quinn JF, Leverenz JB, Brodey M, Schellenberg GD, Kaye JA, Raskind MA, Zhang J, Peskind ER, Montine TJ: CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology 2007;69:631-639.
28. Lehéricy S, Marjanska M, Mesrob L, Sarazin M, Kinkingnehun S: Magnetic resonance imaging of Alzheimer's disease. Eur Radiol 2007;17:347-362.
29. Mattson MP: Pathways towards and away from Alzheimer's disease. Nature 2004;430:631-639.